prasinezumab   Click here for help

GtoPdb Ligand ID: 13330

Synonyms: PRX002 | RG-7935 | RG7935 | RO-7046015 | RO7046015
Compound class: Antibody
Comment: Prasinezumab (RO7046015) is a monoclonal antibody that binds the C-terminus of neurotoxic (aggregated) forms of α-synuclein. It was designed to reduce the cell-to-cell spread of toxic α-synuclein aggregates in the brains of people with Parkinson's disease, as a disease-modifying therapeutic approach to slow the rate of neuronal damage and disease progression.
Click here for help
Bioactivity Comments
Binding avidity for α-synuclein aggregates is substantially higher than for monomeric α-synuclein [3].
Selectivity at other protein targets
Key to terms and symbols Click column headers to sort
Target
Sp.
Type
Action
Value
Parameter
Reference
synuclein alpha Hs Antibody Binding 7.7 – 10.3 pKd - 3
pKd 10.3 (Kd 4.8x10-11 M) [3]
Description: Affinity for aggregated α-synuclein
pKd 7.7 (Kd 2x10-8 M) [3]
Description: Affinity for monomeric α-synuclein
Targets where the ligand is described in the comment field
Target Comment